About Cathepsin E
Cathepsin E (CTSE) is a protein
from Homo sapiens identified by UniProt accession
P14091, 396 residues long.
MolForge cross-references it against 0 known binders and
215 disease associations.
Target properties
| Protein name | Cathepsin E |
| UniProt accession | P14091 |
| Gene | CTSE |
| Organism | Homo sapiens |
| Length | 396 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (215)
Diseases linked to this target (Open Targets).
- prostate carcinoma · score 0.11
- Familial prostate cancer · score 0.11
- prostate cancer · score 0.11
- Barrett's esophagus · score 0.10
- esophageal adenocarcinoma · score 0.07
- graft versus host disease · score 0.05
- bladder transitional cell carcinoma · score 0.05
- sweet syndrome · score 0.05
- neoplasm · score 0.05
- hypotrichosis simplex of the scalp · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P14091-F1 | alphafold | PREDICTED | 87.15 | — |
Amino-acid sequence (396 residues)
MKTLLLLLLV LLELGEAQGS LHRVPLRRHP SLKKKLRARS QLSEFWKSHN LDMIQFTESC SMDQSAKEPL INYLDMEYFG TISIGSPPQN FTVIFDTGSS NLWVPSVYCT SPACKTHSRF QPSQSSTYSQ PGQSFSIQYG TGSLSGIIGA DQVSVEGLTV VGQQFGESVT EPGQTFVDAE FDGILGLGYP SLAVGGVTPV FDNMMAQNLV DLPMFSVYMS SNPEGGAGSE LIFGGYDHSH FSGSLNWVPV TKQAYWQIAL DNIQVGGTVM FCSEGCQAIV DTGTSLITGP SDKIKQLQNA IGAAPVDGEY AVECANLNVM PDVTFTINGV PYTLSPTAYT LLDFVDGMQF CSSGFQGLDI HPPAGPLWIL GDVFIRQFYS VFDRGNNRVG LAPAVP
Explore Cathepsin E with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets